Om

Zentek Ltd. is a Canadian advanced materials and intellectual property company focused on the research, development, and commercialization of graphene-enabled technologies and related nanomaterials. Its current business centers on three core platforms: ZenGUARD antimicrobial coatings, the Albany Graphite Project, and aptamer-based technologies developed through Triera Biosciences. Zentek’s products and technologies are designed for mission-critical applications in clean air, infection prevention, fire suppression, ice-phobic protection, corrosion inhibition, and thermal management. The company works across healthcare, infrastructure, energy, aviation, defense, and industrial markets, using a development-on-demand model that partners with industry to turn specialized materials science into commercial solutions. Headquartered in Guelph, Ontario, Zentek operates as a technology commercialization business with a portfolio built around patented and proprietary nanomaterials.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ZENTEK MED ENDAVU: Køb Zentek ($ZEN) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Zentek, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.